Woltering E A, Emmott R C, Javadpour N, Marx S J, Brennan M F
Surgery. 1981 Jul;90(1):1-9.
Forty-three cases of primary hyperparathyroidism were studied with the specific red cell adherence test (SRCA) to determine the presence or absence of ABO(H) cell surface antigens on abnormal parathyroid tissue. Of the 27 patients with the clinicopathologic diagnosis (CPD) of adenoma, 24 (89%) had lost the ABO(H) cell surface antigen of the abnormal gland. Among the 15 patients with the CPD of hyperplasia, the parathyroid tissue from three (20%) had lost its red cell antigen. In one patient, a metastasis from a parathyroid carcinoma had lost the ABO surface antigen. Several patients in whom conflicting SRCA and CPD were obtained had factors that raised doubts as to the validity of their CPD. The SRCA is a simple test that may aid in the difficult differentiation between parathyroid adenoma and hyperplasia.
对43例原发性甲状旁腺功能亢进患者进行了特异性红细胞黏附试验(SRCA),以确定异常甲状旁腺组织上是否存在ABO(H)细胞表面抗原。在27例经临床病理诊断(CPD)为腺瘤的患者中,24例(89%)异常腺体失去了ABO(H)细胞表面抗原。在15例经CPD诊断为增生的患者中,3例(20%)的甲状旁腺组织失去了红细胞抗原。在1例患者中,甲状旁腺癌转移灶失去了ABO表面抗原。几例SRCA结果与CPD结果不一致的患者存在一些因素,使人对其CPD的有效性产生怀疑。SRCA是一项简单的试验,可能有助于甲状旁腺腺瘤与增生之间的鉴别诊断。